null

SMILES: Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O

InChI Key: InChIKey=HZIGYJWTYPQYBQ-HNWSMCQVSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50469383   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mu-type opioid receptor (Homo sapiens (Human))	BDBM50469383 (CHEMBL4280750) Show SMILES Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O |r| Show InChI InChI=1S/C54H70N12O11/c1-31-25-36(67)26-32(2)37(31)30-38(55)47(70)61-39(19-12-24-60-54(58)59)48(71)64-44(29-35-17-10-5-11-18-35)52(75)66-42(27-33-13-6-3-7-14-33)50(73)62-40(20-22-45(56)68)49(72)65-43(28-34-15-8-4-9-16-34)51(74)63-41(53(76)77)21-23-46(57)69/h3-11,13-18,25-26,38-44,67H,12,19-24,27-30,55H2,1-2H3,(H2,56,68)(H2,57,69)(H,61,70)(H,62,73)(H,63,74)(H,64,71)(H,65,72)(H,66,75)(H,76,77)(H4,58,59,60)/t38-,39+,40-,41-,42-,43-,44-/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	6.20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vrije Universiteit Brussel Curated by ChEMBL					Assay Description Displacement of [3H]DAMGO from human MOR expressed in CHO cell membranes after 60 mins by liquid scintillation counting				J Med Chem 61: 9784-9789 (2018) Article DOI: 10.1021/acs.jmedchem.8b01282 BindingDB Entry DOI: 10.7270/Q2F76G8Q
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Homo sapiens (Human))	BDBM50469383 (CHEMBL4280750) Show SMILES Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O |r| Show InChI InChI=1S/C54H70N12O11/c1-31-25-36(67)26-32(2)37(31)30-38(55)47(70)61-39(19-12-24-60-54(58)59)48(71)64-44(29-35-17-10-5-11-18-35)52(75)66-42(27-33-13-6-3-7-14-33)50(73)62-40(20-22-45(56)68)49(72)65-43(28-34-15-8-4-9-16-34)51(74)63-41(53(76)77)21-23-46(57)69/h3-11,13-18,25-26,38-44,67H,12,19-24,27-30,55H2,1-2H3,(H2,56,68)(H2,57,69)(H,61,70)(H,62,73)(H,63,74)(H,64,71)(H,65,72)(H,66,75)(H,76,77)(H4,58,59,60)/t38-,39+,40-,41-,42-,43-,44-/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	48	n/a	n/a	n/a	n/a
Vrije Universiteit Brussel Curated by ChEMBL					Assay Description Agonist activity at human MOR expressed in CHO cell membranes after 60 mins by [35S]GTPgammaS binding assay				J Med Chem 61: 9784-9789 (2018) Article DOI: 10.1021/acs.jmedchem.8b01282 BindingDB Entry DOI: 10.7270/Q2F76G8Q
					More data for this Ligand-Target Pair